Abstract. MicroRNAs (miRNAs) play critical roles in hepatocellular carcinoma (HCC). However, the expression and biological function of miR-345 in HCC remain unknown. The present study demonstrated that miR-345 expression was reduced in HCC tissues and cell lines. Decreased miR-345 expression was associated with unfavorable clinical features and poor prognosis. In vitro functional assays showed that miR-345 overexpression inhibited the migration and invasion of MHCC-97H cells while miR-345 knockdown promoted metastatic behavior of Hep3B cells. In vivo experiments showed that miR-345 overexpression inhibited while miR-345 knockdown promoted lung metastasis of HCC cells in nude mice. Mechanically, YAP1 was identified to be the downstream target of miR-345 in HCC cells. YAP1 overexpression reversed the inhibitory effects of miR-345 on MHCC-97H migration and invasion, while YAP1 knockdown reduced the promoting effects of miR-345 knockdown on the metastatic behavior of Hep3B cells.
Introduction
Hepatocellular carcinoma (HCC), a lethal disease affecting millions of people worldwide, is the second leading cause of cancer-related death (1) . Patients with HCC in late stage have poor prognosis, with the 5-year survival rate less than 40% (2) . The main reason for the poor survival rate is the occurrence of local and distal metastasis of HCC. Currently, the molecular mechanisms for HCC metastasis largely remain unknown. Investigating the mechanisms of HCC metastasis is important for improving the prognosis of HCC patients.
MicroRNAs (miRNAs) have been found to be important regulators of various biological processes and human diseases (3) (4) (5) (6) . They have been confirmed as critical players in the progression processes of human cancers including HCC (7, 8) . Numerous studies showed that miRNAs were abnormally expressed in HCC tissues, and were found to affect the growth, metastasis and drug resistance of HCC cells (9, 10) . In addition, miRNAs have been regarded as promising biomarkers and treatment targets of HCC (11) .
Among numerous cancer-related diseases, miR-345 is a newly identified cancer-related miRNA. Its expression was decreased in NSCLC tissues and associated with poor prognosis of NSCLC patients (12) . Study of prostate cancer showed that miR-345 inhibited Smad1 and suppressed the growth and metastasis of prostate cancer (13) . In pancreatic cancer, miR-345 inhibited the apoptosis of cancer cells (14) . However, the role of miR-345 in HCC has not been reported.
The present study found that miR-345 expression was decreased in HCC tissues. Decreased expression of miR-345 was related with poor prognosis and unfavorable clinicopathological features of HCC patients. Through the overexpression and knockdown experiments, miR-345 was confirmed to inhibit the migration and metastasis of HCC cells. In vivo experiments showed that miR-345 could inhibit the lung metastasis of HCC cells in nude mice. Moreover, we demonstrated that YAP1 was the downstream target of miR-345 in HCC cells. Targeting YAP1 was required for the biological functions of miR-345 in HCC cells. Statistical analysis. The data are shown as the mean ± standard error (SE) and the statistical analysis was performed with the GraphPad. Student's t-test, Chi-square, correlation analysis and Kaplan-Meier analysis were used in the present study. P<0.05 was regarded as statistically significant.
Materials and methods

Clinical
Results
The expression of miR-345 is reduced in HCC tissues and cells. Eighty pairs of clinical tissues were collected to determine miR-345 expression level in HCC. qRT-PCR showed that HCC tissues had significantly decreased expression level of miR-345 compared with the matched non-tumor tissues 
miR-345 inhibits the metastatic ability of HCC cells in vitro.
As shown in fig. 1D injection experiments. As shown in fig. 5A , overexpression of miR-345 inhibited the metastatic ability of MHCC-97H cells (P<0.05; fig. 5A ), and the number of metastatic nodules in the lung of nude mice was significantly reduced in miR-345 overexpression group (P<0.05; fig. 5B ). On the other hand, knockdown of miR-345 promoted the lung metastasis of Hep3B cells and increased lung metastatic nodules in nude mice (P<0.05; fig. 5C and D).
YAP1 is the downstream target of miR-345 in GC cells.
To further elucidate the underlying mechanisms for the biological functions of miR-345, we used online database to search for the downstream target of miR-345. Among numerous predicted downstream targets, YAP1 is an attractive one since YAP1 is a well-known oncogenic protein in HCC (15, 16) . 3'-UTR of YAP1 contained the binding sequences for miR-345 as shown in fig. 6A . Then, we performed luciferase assay to evaluate whether miR-345 could interact with the 3'-UTR of YAP1. Overexpression of miR-345 significantly reduced the luciferase activity of wild-type YAP1 3'-UTR (P<0.05; fig. 6B ) but had no effect on that of mutant YAP1 3'-UTR. In addition, inhibition of miR-345 increased the luciferase activity of wild-type YAP1 3'-UTR (P<0.05; fig. 6B ) but had no effect on that of mutant YAP1 3'-UTR, indicating that miR-345 can interact with YAP1 3'-UTR through the binding sequences. furthermore, overexpression of miR-345 inhibited the expression of YAP1 in MHCC-97H cells (P<0.05; fig. 6C ). In addition, inhibition of miR-345 significantly enhanced the expression of YAP1 in Hep3B cells (P<0.05; fig. 6D ).
YAP1 is critical for the biological functions of miR-345 in HCC.
After demonstrating that YAP1 was under the regulation of miR-345 in HCC, we further investigated whether YAP1 could mediate the biological function of miR-345 in HCC. YAP1 overexpression vector significantly increased YAP1 expression in MHCC-97H cells overexpressing miR-345 (P<0.05; fig. 7A ). Overexpression of YAP1 in MHCC-97H cells overexpressing miR-345 abrogated the inhibitory effect of miR-345 overexpression on migration (P<0.05; fig. 7B ) and 
Discussion
Molecular mechanisms are under intensive investigation to identify novel therapeutic targets for cancer treatment.
miRNAs are a group of critical players in the development and progression of human cancers (5, 7, 8, (17) (18) (19) . Numerous studies have confirmed that miRNAs were actively involved in the metastatic processes of cancer cells (8) .
Among numerous miRNAs, miR-345 has been identified as a promising tumor associated miRNA. In NSCLC (12), prostate (13) and pancreatic cancer (14) , miR-345 played tumor suppressive roles by affecting apoptosis, proliferation and metastasis. However, miR-345 was found to play oncogenic role in rectal cancer by regulating drug resistance (20) . In the present study, we found that miR-345 was decreased in HCC tissues and cell lines. Decreased miR-345 expression was associated with the poor prognosis of HCC patients. tumor suppressive role in HCC by regulating cell migration and invasion. miR-345 can potentially serve as a promising biomarker for HCC.
YAP1 is a well-known oncogenic protein in human cancer (21) . In HCC, YAP1 was found to be overexpressed and could promote the growth and metastasis of HCC cells (22) . In the present study, we confirmed that YAP1 was the downstream target of miR-345 supported by the data of luciferase assay and western blot analysis. furthermore, YAP1 overexpression could abrogate the inhibitory effects of miR-345 on the HCC cell migration and invasion while YAP1 knockdown reversed the promoting effect of miR-345 inhibition on HCC cells migration and invasion, indicating that YAP1 was not only the downstream target of miR-345 but also the mediator of the biological functions of miR-345 in HCC.
In summary, the present study demonstrated that miR-345 was decreased in HCC tissues and cell lines. Decreased level of miR-345 was associated with decreased survival rate of HCC patients. miR-345 was found to reduce the migration and invasion ability of HCC cell both in vitro and in vivo. Moreover, we found for the first time that YAP1 was the downstream target of miR-345 in HCC. Inhibition of YAP1 was required for the inhibitory effects of miR-345 on the migration and invasion of HCC cells.
